Payment Type: | L/C,T/T |
---|---|
Min. Order: | 1 Gram |
Model No.: 284461-73-0
Brand: CONBOTTPHARM
Packaging: AS Required
Productivity: Customized
Transportation: Ocean,Air
Place of Origin: CHINA
Supply Ability: Commercial
Certificate: DOCUMENT SUPPORT
Payment Type: L/C,T/T
We supply a great number of sorafenib tosylate CAS No.284461-73-0 with high quality. Sorafenib CAS 284461-73-0 is a white to yellowish or brownish crystalline solid .Sorafenib tosylate 284461-73-0 is an anti-cancer drug which is approved to treat hepatocellular carcinoma that cannot be removed by surgery and renal cell carcinoma that is advanced. Sorafenib also treats thyroid cancer in certain patients with progressive, recurrent, or metastatic disease that does not respond to treatment with radioactive iodine. Sorafenib 284461-73-0 takes effect by multiplying kinase inhibitor targeting both RAF kinase and receptor tyrosine kinases that promote angiogensis.
Thera. Category: Anti cancer
Cas No.: 284461-73-0
Synonyms: sorafenib;SORAFENIB-D3;SORAFENIB TOLSYLATE;RAF1 KINASE INHIBITOR II;N-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)-((4-(2-(N-METHYL-CARBAMOYL)(4-PYRIDYLOXY))PHENYL)AMINO)CARBOXAMIDE;4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-n-methyl-pyridine-2-carboxamide;BAY 43-9006;SORAFENIB MESYLATE
Molecular Formula: C21H16ClF3N4O3
Molecular Weight: 425.47
Assay: ≥99%
Packing: Export worthy packing
Material Safety Data Sheet: Available on request
Usage: Sorafenib tosylate is also being studied in the treatment of other types of cancer
Product Categories : Intermediates > Anti-Viral Intermediate